Approach to the Ground-Glass Nodule

Slides:

Advertisements

Similar presentations

Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis Alessandro Marra, MD, PhD, Ludger Hillejan, MD,

Advertisements

Multifocal adenocarcinoma in situ (AIS), formerly known as bronchioloalveolar cell carcinoma (BAC). (A, B) Two chest CT sections obtained approximately.

Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies Sai-Hong Ignatius Ou, MD,

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

A Proposal for Definition of Minimally Invasive Adenocarcinoma of the Lung Regardless of Tumor Size Shigeki Suzuki, MD, Hiroyuki Sakurai, MD, Kyohei.

Now or Later: Evaluating the Importance of Chemotherapy Timing in Resectable Stage III (N2) Lung Cancer in the National Cancer Database Daniel J. Boffa,

Pannus Attack: Septic Thrombophlebitis

The Lung Reporting and Data System (LU-RADS): A Proposal for Computed Tomography Screening Daria Manos, MD, Jean M. Seely, MD, Jana Taylor, MD, Joy Borgaonkar,

A Novel Classification of MUC1 Expression Is Correlated with Tumor Differentiation and Postoperative Prognosis in Non–Small Cell Lung Cancer Shinjiro.

Surgical–pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non– small cell lung cancer: A heterogeneous disease Chung-Ping Hsu, MD,

Volume 142, Issue 6, Pages (December 2012)

Ground glass opacities: Imaging, pathology, and gene mutations

Fate of Newly Detected Lesions During Postoperative Surveillance for Non-Small Cell Lung Cancer Jae-Ik Lee, MD, PhD, Young-Jin Lee, RN, Kook-Yang Park,

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system Shamus R.

Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,

Details and Difficulties Regarding the New Lung Cancer Staging System

Prognostic Impact of Margin Distance and Tumor Spread Through Air Spaces in Limited Resection for Primary Lung Cancer Kyohei Masai, MD, Hiroyuki Sakurai,

Tetsuya Mitsudomi, MD, Hirohito Tada, MD Journal of Thoracic Oncology

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer Hong.

Cigarette Smoking Associated With Lung Adenocarcinoma In Situ in a Large Case- Control Study (SFBALCS) Paige M. Bracci, PhD, Jennette Sison, MPH, Helen.

Percutaneous Computed Tomography-Guided Coaxial Core Biopsy for Small Pulmonary Lesions with Ground-Glass Attenuation Chia-Hung Lu, MD, FRCR, Cheng-Hsiang.

Neither Maximum Tumor Size nor Solid Component Size Is Prognostic in Part-Solid Lung Cancer: Impact of Tumor Size Should Be Applied Exclusively to Solid.

Importance of Ground Glass Opacity Component in Clinical Stage IA Radiologic Invasive Lung Cancer Aritoshi Hattori, MD, Takeshi Matsunaga, MD, Kazuya.

Turning Gray: The Natural History of Lung Cancer Over Time

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Frank Detterbeck, MD Journal of Thoracic Oncology

Combined Resection of Superior Vena Cava for Lung Carcinoma: Prognostic Significance of Patterns of Superior Vena Cava Invasion Kenji Suzuki, MD, Hisao.

Superselective Segmentectomy for Deep and Small Pulmonary Nodules Under the Guidance of Three-Dimensional Reconstructed Computed Tomographic Angiography

Conditional Cancer-Specific Versus Cardiovascular-Specific Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Shawn S. Groth, MD, MS, Natasha.

Photodynamic Therapy for Early Stage Central Type of Lung Cancer

Ugo Pastorino, MD, Marc Buyse, ScD, Godehard Friedel, MD, Robert J

Prognostic Factors in Patients with Pathologic T1-2N1M0 Disease in Non-small Cell Carcinoma of the Lung Katsunari Matsuoka, MD, Shinichi Sumitomo, MD,

Epidermal Growth Factor Receptor Mutation and p53 Overexpression during the Multistage Progression of Small Adenocarcinoma of the Lung Seol Bong Yoo,

Nomogram for Predicting the Risk of Invasive Pulmonary Adenocarcinoma for Pure Ground-Glass Nodules Lijie Wang, MD, Weiyu Shen, MD, Yong Xi, MD, Shuai.

Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non–Small Cell Lung Cancer Aritoshi Hattori, MD,

Mediastinal Lymph Node Examination and Survival in Resected Early-Stage Non– Small-Cell Lung Cancer in the Surveillance, Epidemiology, and End Results.

Treatment of Carcinoma of the Esophagus or Cardia*

Segmentectomy for selected cT1N0M0 non–small cell lung cancer: A prospective study at a single institute Hiroaki Nomori, PhD, Takeshi Mori, PhD, Koei.

Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical Subtype Ting Ye, MD, PhD, Lin Deng, MD, Shengping Wang,

Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer Raymond U.

A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions Hisao Asamura, MD, Kenji Suzuki,

Are There Imaging Characteristics Associated with Epidermal Growth Factor Receptor and KRAS Mutations in Patients with Adenocarcinoma of the Lung with.

Radiologic Classification of Small Adenocarcinoma of the Lung: Radiologic-Pathologic Correlation and Its Prognostic Impact Kenji Suzuki, MD, Masahiko.

Subclavian artery involvement by apical chest tumors: A specific indication for the transmanubrial approach Lorenzo Spaggiari, MD, PhD, Ugo Pastorino,

Epidermal Growth Factor Receptor Mutation and Pathologic-Radiologic Correlation Between Multiple Lung Nodules with Ground-Glass Opacity Differentiates.

Prognostic Impact of Node Involvement Pattern in Pulmonary pN1 Squamous Cell Carcinoma Patients Masayuki Nakao, MD, Junji Yoshida, MD, PhD, Genichiro.

Navigating the lung for hidden treasure

Selective Mediastinal Lymphadenectomy for Clinico-Surgical Stage I Non–Small Cell Lung Cancer Morihito Okada, MD, PhD, Toshihiko Sakamoto, MD, PhD, Tsuyoshi.

Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis Alessandro Marra, MD, PhD, Ludger Hillejan, MD,

Clinicopathologic Features and Computed Tomographic Findings of 52 Surgically Resected Adenosquamous Carcinomas of the Lung Yukio Watanabe, MD, Koji.

Nabil P. Rizk, MD, Venkatraman E. Seshan, PhD, Manjit S

Yuji Tachimori, MD, Hoichi Kato, MD, Hiroshi Watanabe, MD

“Early” peripheral lung cancer: prognostic significance of ground glass opacity on thin- section computed tomographic scan Kenji Suzuki, MD, Hisao Asamura,

Olga Vornicova, MD, Gil Bar-Sela, MD JAAD Case Reports

Long-Term Outcomes of 50 Cases of Limited-Resection Trial for Pulmonary Ground- Glass Opacity Nodules Masayuki Nakao, MD, Junji Yoshida, MD, PhD, Koichi.

Carcinoma of the esophagus: Prognostic significance of histologic type

O. S. Breathnach, MDa, D. J. Kwiatkowski, MD, PhDb, D. M

Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,

Multifocal lung cancer within ground glass lesions: Are favorable outcomes consequent to surgical resection or inherent to the disease? Mara B. Antonoff,

Journal of Thoracic Oncology

Robert J. Cerfolio, MD, FACS, FCCP, Ayesha S. Bryant, MSPH, MD

Influence of Ground Glass Opacity and the Corresponding Pathological Findings on Survival in Patients with Clinical Stage I Non–Small Cell Lung Cancer

Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma.

Aritoshi Hattori, MD, Kenji Suzuki, MD

Medically Complex Patients

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

Is there a benefit to continuing with resection of all sites of disease when clinically occult pleural metastases from non–small cell carcinoma are found?

Visceral Pleural Invasion Is Not a Significant Prognostic Factor in Patients With a Part- Solid Lung Cancer Aritoshi Hattori, MD, Kenji Suzuki, MD, Takeshi.

Presentation transcript:

Approach to the Ground-Glass Nodule Frank C. Detterbeck, MD, Robert J. Homer, MD, PhD Clinics in Chest Medicine Volume 32, Issue 4, Pages 799-810 (December 2011) DOI: 10.1016/j.ccm.2011.08.002 Copyright © 2011 Elsevier Inc. Terms and Conditions

Fig. 1 Suzuki classification of GGOs. Radiographic classification of lung nodules according to the ground-glass component by Suzuki and colleagues.2 (Data from Suzuki K, Kusumoto M, Watanabe S, et al. Radiologic classification of small adenocarcinoma of the lung: radiologic-pathologic correlation and its prognostic impact. Ann Thorac Surg 2006;81:413–9.) Clinics in Chest Medicine 2011 32, 799-810DOI: (10.1016/j.ccm.2011.08.002) Copyright © 2011 Elsevier Inc. Terms and Conditions

Fig. 2 Findings at resection of a GGO. Distribution of diagnoses of resected lesions for (A) pure GGO and (B) semisolid GGO lesions. AAH, atypical adenomatous hyperplasia; Adeno, adenocarcinoma; AIS, adenocarcinoma in situ; F/U mo, follow-up period (in months); N pts, number of patients. (Part (A) Data from Refs.15,26,44,46,73–75; and (B) Data from Refs.12,15,26,46,59,60,74–77) Clinics in Chest Medicine 2011 32, 799-810DOI: (10.1016/j.ccm.2011.08.002) Copyright © 2011 Elsevier Inc. Terms and Conditions

Fig. 3 Diagnosis according to size. Diagnosis according to size for (A) pure GGO and (B) semisolid GGO. AAH, atypical adenomatous hyperplasia; Adeno, adenocarcinoma; AIS, adenocarcinoma in situ; F/U mo, follow-up period (in months); N pts, number of patients; NSCLC, non–small cell lung carcinoma. (Part (A) Data from Refs.17,46,58,60,78; and (B) Data from Refs.46,59,75) Clinics in Chest Medicine 2011 32, 799-810DOI: (10.1016/j.ccm.2011.08.002) Copyright © 2011 Elsevier Inc. Terms and Conditions

Fig. 4 Outcomes during observation. Outcomes of GGO lesions after a period of observation. BAC, bronchioloalveolar carcinoma; F/U mo, follow-up period (in months); N pts, number of patients. (Data from Refs.10,15–17,57,60,79) Clinics in Chest Medicine 2011 32, 799-810DOI: (10.1016/j.ccm.2011.08.002) Copyright © 2011 Elsevier Inc. Terms and Conditions

Fig. 5 Diagnoses during observation. Diagnoses made during observation. AAH, atypical adenomatous hyperplasia; Adeno, adenocarcinoma; AIS, adenocarcinoma in situ; F/U mo, follow-up period (in months); N pts, number of patients. (Data from Refs.10,15–17,57,60,73,79) Clinics in Chest Medicine 2011 32, 799-810DOI: (10.1016/j.ccm.2011.08.002) Copyright © 2011 Elsevier Inc. Terms and Conditions